Publications:

BRCA1 and BRCA2 founder mutations account for 78% of germline carriers among hereditary breast cancer families in Chile.

Oncotarget

Alvarez, Carolina C; Tapia, Teresa T; Perez-Moreno, Elisa E; Gajardo-Meneses, Patricia P; Ruiz, Catalina C; Rios, Mabel M; Missarelli, Claudio C; Silva, Mariela M; Cruz, Adolfo A; Matamala, Luis L; Carvajal-Carmona, Luis L; Camus, Mauricio M; Carvallo, Pilar P

Publication Date: 2017-09-26

Variant appearance in text: BRCA2: 316+73A>G

PubMed Link: 29088781

Variant Present in the following documents:

• Main text
• oncotarget-08-74233.pdf

View BVdb publication page